The impact of comorbidities on therapy-optimization and their prognostics role among hospitalized patients with heart failure with reduced ejection fraction

Back

ESC Professional Premium Access

The impact of comorbidities on therapy-optimization and their prognostics role among hospitalized patients with heart failure with reduced ejection fraction

Session: Heart and kidney in heart failure: no end to the dangerous liaison

Topic: Comorbidities

Speaker: Doctor B. Muk (Budapest, HU)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Balazs Muk

Gottsegen National Cardiovascular Center, Budapest (Hungary)

2 presentations

0 follower

4 more presentations in this session

Heart failure and advanced chronic kidney disease: differences in characteristics, treatment and outcomes in patients with glomerular filtration rate greater or less than 30 ml/minute/m2

Speaker: Doctor A. Recio Mayoral (Seville, ES)

Chronic kidney disease in patients with heart failure in German primary care practices: the InspeCKD study

Speaker: Professor T. Frese (Halle, DE)

Validation of existing risk scores for worsening renal function in patients with newly diagnosed heart failure: a longitudinal population cohort study

Speaker: Professor C. Lang (Dundee, GB)

Kidney status and events preceding death in heart failure: A real world data study on 18,456 patients with heart failure

Speaker: Mrs D. Zahir (Gentofte, DK)

Access the full session

Heart and kidney in heart failure: no end to the dangerous liaison

Speakers: Doctor B. Muk, Doctor A. Recio Mayoral, Professor T. Frese, Professor C. Lang, Mrs D. Zahir

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources